About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
Previous Close | $0.69 | Open | $0.70 |
Volume | 16.56M | Market Cap | 141.63M |
Yield | Last Dividend |
Onconova Therapeutics, Inc. Announces $8... | 01/07/21 |
NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (???Onconova???), a biopharmaceutical company focused on??? |
Thinking about buying stock in Sundial G... | 12/02/20 |
NEW YORK, Dec. 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, ZOM, AMD, JAGX, and ONTX. To see how InvestorsObs... |
72 Biggest Movers From Yesterday | 12/02/20 |
Gainers Auris Medical Holding Ltd. (NASDAQ: EARS ) shares jumped 371% to close at $5.23 on Tuesday after the company reported positive efficacy data f... |
Thinking about buying stock in Jaguar He... | 12/01/20 |
NEW YORK, Dec. 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, ZOM, SNDL, ONTX, and RIG. To see how InvestorsObs... |
Onconova Therapeutics Files Investigatio... | 11/23/20 |
U.S. Phase 1 trial patient enrollment to begin in the first half of 2021China Phase 1 trial enrollment ongoingKey regulatory milestone achieved to ena... |
Recent Updates on Anal Cancer Drug Marke... | 11/18/20 |
Global Anal Cancer Drug Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sa... |
Onconova Therapeutics to Provide Corpora... | 11/05/20 |
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12 |
Onconova Therapeutics (NASDAQ:ONTX) Shar... | 10/22/20 |
Onconova Therapeutics Inc (NASDAQ:ONTX) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day movin... |
Onconova Therapeutics Inc (NASDAQ:ONTX) ... | 10/20/20 |
Shares of Onconova Therapeutics Inc (NASDAQ:ONTX) have been given a consensus recommendation of ???Hold??? by the six brokerages that are covering the... |
Onconova Therapeutics Highlights Corpora... | 08/12/20 |
INSPIRE Phase 3 trial survival events reachedTopline data anticipated Q3-2020 Conference call and webcast scheduled today, August 12, at 4:30 p.m. ET ... |
Onconova Therapeutics to Provide Corpora... | 08/07/20 |
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12 |
Onconova Therapeutics Announces that the... | 07/29/20 |
Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020 |
Onconova files for NIH funding for studi... | 07/27/20 |
Onconova Therapeutics (NASDAQ:ONTX) has submitted an application to the National Institute of Allergy and Infectious Disease (NIAID) aimed at obtainin... |
Onconova Therapeutics Submits Applicatio... | 07/27/20 |
Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replicationNEWTOWN, Pa., July 27, 2020 (GLOBE N... |
Onconova Therapeutics Announces Particip... | 06/23/20 |
NEWTOWN, Pa., June 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on??? |
Onconova Therapeutics : SCHEDULE 14A | M... | 06/11/20 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??? | June 11, 2020 |
Onconova Therapeutics (ONTX): FY2019 Ear... | 03/25/20 |
??? Onconova Therapeutics (NASDAQ: ONTX) reported FY2019 net loss of $1.49 per share, vs. $4.99 per share last year. ??? Net loss was $21.5 million co... |
Onconova (ONTX) to Report Q4 Earnings: W... | 03/02/20 |
Onconova (ONTX) will focus on the updates on lead candidate, Rigosertib, when it reports fourth-quarter 2019 results. |
Onconova regains rigosertib rights in Ch... | 01/23/20 |
Onconova Therapeutics (NASDAQ:ONTX) is up 17% premarket on robust volume in reaction to its announcement that it has regained the rights to rigosertib... |
Onconova Therapeutics, Inc. Announces $1... | 12/31/19 |
NEWTOWN, Pa., Dec. 31, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (???Onconova??? or the ???Company???), a Phase 3-stage??? |
Onconova Therapeutics, Inc. Announces Cl... | 11/25/19 |
Offering led by healthcare dedicated funds, including Knight Therapeutics Inc., along with officers and directors of Onconova |
The Daily Biotech Pulse: Roche-Spark Dea... | 11/22/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.... |
The Daily Biotech Pulse: Therapix Extend... | 10/11/19 |
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs O... |
The Daily Biotech Pulse: Arbutus Halts H... | 10/04/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Ap... |
The Daily Biotech Pulse: Enanta Aces Mid... | 09/26/19 |
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... |
The Daily Biotech Pulse: PhaseBio Leaps ... | 09/25/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 24)... |
Onconova Therapeutics (ONTX) May Report ... | 08/06/19 |
Onconova (ONTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... |
Week In Review: MGI Tech Raises $200 Mil... | 05/19/19 |
No summary available. |
Onconova Therapeutics, Inc. (ONTX) CEO S... | 05/14/19 |
No summary available. |
Onconova Therapeutics misses by $0.26, m... | 05/14/19 |
No summary available. |
Date | 2020-11-12 (AMC) | Est. (EPS/Rev.) | ($0.03)/ 1.39M |
Actual (EPS/Rev.) | $-0.03/ $66.00 K | EPS (TTM) | 0 |
Total Revenue | $1.3B | Total Liabilities | $2.1B |
Cost of Revenue | $2.5B | Total cash flow | $3.2 |
Total Assets | $29.98B |
% Insider | 12.52% | % Institutional | 76.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Service Name | Trader | % Success | |
---|---|---|---|
Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
Tech Trades | Tech Trades | 81.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.